Corcept Therapeutics to Announce Second Quarter 2013 Financial Results and Host Conference Call
August 01 2013 - 4:05PM
Marketwired
Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it
will report second quarter 2013 financial results on August 8,
2013. The Company will host a conference call that day at 5:00 p.m.
Eastern Time (2:00 p.m. Pacific Time).
Conference Call Information
To participate, dial 1-888-771-4371 from the United States or
+1-847-585-4405 internationally approximately 10 minutes before the
start of the call. The passcode is 35403018.
A replay will be available through August 22, 2013 at
1-888-843-7419 from the United States and +1-630-652-3042
internationally. The passcode is 35403018.
About Corcept Therapeutics
Incorporated
Corcept is a pharmaceutical company engaged in the discovery,
development and commercialization of drugs for the treatment of
severe metabolic and psychiatric disorders. Korlym, a first
generation competitive GR-II antagonist, is the company's first
FDA-approved medication. The company has a phase 3 trial underway
for mifepristone for treatment of the psychotic features of
psychotic depression and a portfolio of selective GR-II antagonists
that competitively block the effects of cortisol but not
progesterone. It owns extensive intellectual property covering the
use of GR-II antagonists, including mifepristone, in the treatment
of a wide variety of metabolic, psychiatric and other disorders. It
also holds composition of matter patents for its selective GR-II
antagonists.
CONTACT: Charles Robb Chief Financial Officer Corcept
Therapeutics 650-688-8783 Email Contact www.corcept.com
Corcept Therapeutics (NASDAQ:CORT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Corcept Therapeutics (NASDAQ:CORT)
Historical Stock Chart
From Apr 2023 to Apr 2024
